1-4 of 4
Mira Patel Pochron
Close
Sort by
Journal Articles

Preliminary Results from a Multicenter Phase 2/3 Study of Next-Generation HbS Polymerization Inhibitor GBT021601 for the Treatment of Patients with Sickle Cell Disease

Santosh L. Saraf, Shehu Umar Abdullahi, Adeseye Michael Akinsete, Foluke A Fasola, Modupe Idowu, Sharon Pennington, William B Ershler, Marshall Patrick Stagg, Wai Chin, Eric Zimmerman, Adeyemi Adenola, Mira Patel Pochron, Eleanor A Lisbon
Journal: Blood
Blood (2023) 142 (Supplement 1): 274.
https://doi.org/10.1182/blood-2023-177781
Published: 2023
Journal Articles

Preliminary Pharmacodynamic Results from a Multicenter Phase 2/3 Study of Next-Generation HbS Polymerization Inhibitor GBT021601 for the Treatment of Patients with Sickle Cell Disease

Mira Patel Pochron, Adeseye Michael Akinsete, Shehu Umar Abdullahi, Foluke A Fasola, Modupe Idowu, Sharon Pennington, William B Ershler, Marshall Patrick Stagg, Earl Fields, Morgan Sterling, Satheesh Chonat, Yuvika Paliwal, Karena Kong, David R Archer, Adeyemi Adenola, Eleanor A Lisbon
Journal: Blood
Blood (2023) 142 (Supplement 1): 1155.
https://doi.org/10.1182/blood-2023-188929
Published: 2023
Journal Articles

Predictive Biomarker Analysis from the GBT021601 Survival Study in Townes Sickle Mice

Mira Patel Pochron, Jiaxin Sun, Alka A Potdar, Carsten Alt, Francis DeGuzman, Michael W. Connor, Brian Cathers, Kobina Dufu, David R Archer
Journal: Blood
Blood (2023) 142 (Supplement 1): 14.
https://doi.org/10.1182/blood-2023-177776
Published: 2023
Journal Articles

Evaluation of GBT021601 As a Therapeutic Agent to Restore Bone Marrow Health and Effective Erythropoiesis in a Sickle Mouse Model

Britney Hernandez, Anupama Priyadarshini, Zachary Kostamo, Yankai Zhang, Ashwin P Patel, Michael A Pendergast, Madhulika Jupelli, Heli Huang, Annie Nguyen Dang, Mira Patel Pochron, Kobina Dufu, Vivien A Sheehan
Journal: Blood
Blood (2023) 142 (Supplement 1): 16.
https://doi.org/10.1182/blood-2023-175022
Published: 2023